Ionizing radiation is a form of energy released by atoms in the form of electromagnetic waves such as gamma, x-rays or particles such as neutrons, beta or alpha. The disintegration of atoms is called ...

The former president, 82, was surrounded by family as he celebrated the end of his cancer treatment Meredith Kile is a Digital News Writer-Editor at PEOPLE. She has been an entertainment and political ...

Former President Joe Biden completed a round of radiation treatment for his aggressive form of prostate cancer on Monday. Biden had been undergoing treatment at Penn Medicine Radiation Oncology in ...

Former President Joe Biden reached a milestone in his cancer treatment Monday — he rang the bell to signal the end of his radiation treatment. As of now, it is not clear if Biden will need any further ...

Biden, 82, celebrated the milestone at Penn Medicine Radiation Oncology in Philadelphia by taking part in the traditional ringing of the bell, a ritual that marks the end of treatment for a cancer ...

Former President Joe Biden has completed a course of radiation therapy after being diagnosed in May with an "aggressive form" of prostate cancer, according to a spokesperson. Biden's daughter Ashley ...

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...

It's unclear if he'll need more radiation treatment, his spokesperson says. Former President Joe Biden has completed his current course of radiation therapy, a spokesperson told ABC News on Monday. It ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF). This is the first new therapy in more than 10 years to be approved for ...

Former President Joe Biden is undergoing a five-week radiation regimen as part of his treatment for prostate cancer, his office said Saturday. Biden was already taking a hormone medication pill, and ...

Please provide your email address to receive an email when new articles are posted on . The FDA based nerandomilast’s approval on results from two trials, one of which was the FIBRONEER-IPF trial.